ESR2 and cancer: Furthermore, the same decreased dosage of ERβ gene increases the proportion of tumors with features of EMT, suggesting that loss of the receptor is associated with more aggressive neoplasms and cancer cells that have higher potential to invade and metastasize to distant sites.